Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

South Korean women with hair loss have lower hair density and thickness compared to healthy women.

The document concludes that female pattern baldness involves hair thinning, is classified differently than in men, and is assessed using the Ludwig classification. It also explains the hair growth cycle stages.

Monofilament Threads significantly improve hair growth in women with pattern hair loss and are safe.

Platelet-rich plasma injections effectively treat hair loss in both men and women, increasing hair density with high patient satisfaction and no significant side effects.

More men have Androgenic Alopecia than women, it's often inherited, and stress can contribute to it.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Some skin conditions look like acne but are caused by drugs, and they usually get better when the drug is stopped.

Ephrins slow down skin and hair follicle cell growth.

The combined treatment improved scalp health in women with early-stage hair loss.

Certain plant extracts can effectively treat skin conditions like athlete's foot, chronic vein problems, sun damage, skin growths, vitiligo, and hair loss, and may also improve skin appearance.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Mast cells might contribute to hair loss by causing skin thickening.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with androgenetic alopecia have fewer terminal hairs, phenol in nail surgery is safe, and a new hair transplant method is faster and less damaging.

Hair loss causes social and psychological stress, leading people to spend more on treatment, regardless of how severe the hair loss is.

There may be a link between hair loss and heart disease in women, but more research is needed.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

The combined therapy significantly increased hair density and was safe for treating hair loss.

Adding the topical gel improved hair growth more than using minoxidil or finasteride alone.

Androgenetic Alopecia (AGA) greatly lowers quality of life, causing stress and low self-esteem, with those seeking treatment experiencing more impairment.